Caprock Group LLC Lowers Stake in Cardinal Health, Inc. (NYSE:CAH)

Caprock Group LLC decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.9% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 20,896 shares of the company’s stock after selling 1,070 shares during the period. Caprock Group LLC’s holdings in Cardinal Health were worth $2,471,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Eastern Bank purchased a new position in shares of Cardinal Health during the 3rd quarter worth $25,000. Frazier Financial Advisors LLC grew its position in shares of Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after purchasing an additional 104 shares during the period. Hara Capital LLC acquired a new position in Cardinal Health in the third quarter valued at $31,000. AM Squared Ltd purchased a new position in Cardinal Health during the third quarter worth about $33,000. Finally, Carolina Wealth Advisors LLC acquired a new stake in Cardinal Health in the 3rd quarter worth about $47,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on CAH shares. JPMorgan Chase & Co. upped their price objective on shares of Cardinal Health from $132.00 to $142.00 and gave the company a “neutral” rating in a research note on Friday, January 24th. Citigroup increased their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Barclays boosted their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and increased their target price for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Finally, Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target for the company in a research report on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $135.64.

Cardinal Health Stock Down 3.7 %

Shares of NYSE:CAH opened at $123.56 on Friday. The company has a 50 day moving average of $122.03 and a two-hundred day moving average of $114.19. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84. The company has a market capitalization of $29.90 billion, a price-to-earnings ratio of 24.04, a price-to-earnings-growth ratio of 1.55 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. On average, equities analysts anticipate that Cardinal Health, Inc. will post 7.84 earnings per share for the current year.

Cardinal Health Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were paid a dividend of $0.5056 per share. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.64%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.